Different policy outcomes of the new drugs and currently listed drugs under the positive list system in South Korea

Value in Health

Volumn 15, Issue 1 SUPPL., 2012, Pages

  Lee, Eui Kyung ^a   Kim, Bo Yeon ^b   Lim, Jae Young ^c   Park, Mi Hai ^d  

^a Sookmyung Women's University   (South Korea)

^b Health Insurance Review & Assessment Service Korea   (South Korea)

^c Korea University   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

drug expenditure; economic evaluation; positive list; reimbursement

Indexed keywords

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DRUG COST; DRUG EFFICACY; DRUG FORMULARY; DRUG LEGISLATION; DRUG SCREENING; ECONOMIC EVALUATION; EVIDENCE BASED MEDICINE; POLITICAL PARTICIPATION; PRIORITY JOURNAL; REIMBURSEMENT; SOUTH KOREA;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; FORMULARIES AS TOPIC; HEALTH POLICY; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MODELS, ECONOMIC; NATIONAL HEALTH PROGRAMS; POLITICS; REPUBLIC OF KOREA;

EID: 84862954016     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1016/j.jval.2011.11.017     Document Type: Conference Paper

References (11)

1. Ministry of HealthWelfare Policy Measures to Optimize Drug Expenditure 2006 Ministry of Health and Welfare Gwacheon, South Korea
2. S.Y. Lee Price control of reimbursable drugs J Pharm Pol Res 3 2008 6 23
3. E.Y. Bae, E.K. Lee Pharmacoeconomic guidelines and their implementation in the positive list system in South Korea Value Health 12 Suppl. 3 2009 S36 S41
4. Health Insurance Review and Assessment Service, Internal Report Seoul, South Korea 2010
5. B.Y. Kim Health care reimbursement decision-making in Korea: policymaker perspectives 2010 ISPOR 4th Asia-Pacific Conference, First Plenary Session Phuket, Thailand
6. E.Y. Bae, J.H. Kim, S.E. Choi Use of Pharmacoeconomic Data in Reimbursement Decision Making Process 2005 Health Insurance Review and Assessment Service Seoul, South Korea
7. Ministry of Health and Welfare, Health Insurance Review and Assessment Service Forum on Positive List System for the Currently-Listed Drugs 2008 Ministry of Health and Welfare Seoul, South Korea
8. B.M. Yang, E.Y. Bae, J. Kim Economic evaluation and pharmaceutical reimbursement reform in South Korea's National Health Insurance Health Aff (Millwood) 27 2008 179 187 (Pubitemid 351198603)
9. D.M. Ha Analysis of the Current Performance of New Drugs Reimbursement and Perception on Policy after Introducing Positive List System in Korea 2010 Sungkyunkwan University Suwon, South Korea PhD dissertation
10. J.H. Kim, C.W. Kim, S.H. Lee Re-evaluation of Effectiveness and Adverse Reaction of Hypertensive Drugs for the Positive List of Currently-Listed Drugs 2010 Seoul National University Seoul, South Korea
11. Drug Reimbursement Evaluation Committee Detailed Guidelines for the Assessment of Cost-Effectiveness of Incrementally Modified Drugs 2008 Health Insurance Review and Assessment Service Seoul, South Korea